Envoy Medical Sets October 12 Vote on 1-for-5 to 1-for-25 Reverse Split to Avoid Nasdaq Delisting
COCH sits 99% above its 52-week low of $0.363 on light trading volume (0.1× avg).
Summary
Envoy Medical shareholders will vote October 12 on a reverse stock split ranging from 1-for-5 to 1-for-25 to regain Nasdaq's $1.00 minimum bid price compliance before the November 16 deadline.
Key Events · Corporate Governance and Compliance · COCH
-
Reverse Split Vote Set for October 12
Special meeting scheduled for October 12, 2026 to approve a reverse stock split at a ratio between 1-for-5 and 1-for-25, with board discretion to implement any time before December 31, 2026.
-
Nasdaq Delisting Deadline November 16
Company must regain $1.00 minimum bid price compliance by November 16, 2026. Stock currently trades at $0.72, well below the threshold.
-
Share Count Reduction
77,394,595 shares outstanding as of August 19, 2026 record date. A 1-for-5 split would reduce to ~15.5M shares; a 1-for-25 split to ~3.1M shares.
-
Financing Access at Stake
Maintaining Nasdaq listing preserves Form S-3 shelf eligibility. Delisting would severely limit capital raising options while cash runway extends only to Q1 2027.
Analysis · COCH · Industrial Applications And Services
Envoy Medical is asking shareholders to approve a reverse stock split at a special meeting on October 12, 2026. The company needs to lift its stock price above $1.00 by November 16, 2026 to avoid delisting from Nasdaq. The board can choose any ratio between 1-for-5 and 1-for-25, giving it flexibility to react to market conditions. With 77.4 million shares outstanding and a stock price of $0.72, the split would reduce the share count to between 15.5 million and 3.1 million shares. The company's cash runway only extends to Q1 2027, so maintaining Nasdaq listing is critical for future financing access.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.1% of the 2014 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, COCH was trading at $0.72 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $56.3M. The 52-week trading range was $0.36 to $1.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.